Clinical Trial Update: Evaluation of Serum Procalcitonin Rate in Patients With Stage IV Non-small Cell Lung Cancer in First Line Chemotherapy

View source ↗

Summary

A clinical trial evaluating serum procalcitonin levels in patients with stage IV non-small cell lung cancer undergoing first-line chemotherapy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: Centre Hospitalier Universitaire, Amiens | Conditions: Non Small Cells Lung Cancer | Status: UNKNOWN